Hyperglycemia Affects the Expression of Inflammatory Genes in Peripheral Blood Mononuclear Cells of Patients with Type 2 Diabetes

Objective: Innate immune system dysregulation and chronic low-grade inflammation are associated with the pathogenesis of type 2 diabetes (T2D). The aim of this study was to investigate the effect of hyperglycemia on mRNA expression of four inflammatory genes in peripheral blood mononuclear cells (PB...

Full description

Saved in:
Bibliographic Details
Published inImmunological investigations Vol. 47; no. 7; pp. 654 - 665
Main Authors Akbari, Mohamad, Hassan-Zadeh, Vahideh
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 03.10.2018
Subjects
Online AccessGet full text
ISSN0882-0139
1532-4311
1532-4311
DOI10.1080/08820139.2018.1480031

Cover

Abstract Objective: Innate immune system dysregulation and chronic low-grade inflammation are associated with the pathogenesis of type 2 diabetes (T2D). The aim of this study was to investigate the effect of hyperglycemia on mRNA expression of four inflammatory genes in peripheral blood mononuclear cells (PBMCs) of pre-diabetic and diabetic individuals. Methods: In a case-control study, quantitative real-time PCR was used to analyze changes in IL-1β, IL1R1, IL-6, and IL6ST gene expression in PBMCs of 30 T2D patients with high blood glucose levels, 24 diabetic and nondiabetic individuals with moderately high blood glucose levels and 30 controls with normal blood glucose levels. Results: In T2D patients with high blood glucose, IL-1β expression showed a 2.69-fold increase (p = 0.0380), while IL-6 expression levels were 3.45 fold lower (p = 0.0045) versus control subjects. Moreover, compared with control group the expression of IL1R1 and IL-6 genes both were downregulated in individuals with moderately high blood glucose levels by 2.38 (p = 0.0365) and 4.34 fold (p = 0.0027), respectively. In addition, hemoglobin A1C (A1C) levels were positively correlated with IL-1β expression and fasting plasma glucose (FPG) levels showed a positive correlation with IL-1β and a negative correlation with IL-6 expression. Conclusion: The observed changes in both IL-1β and IL-6 mRNA levels in PBMCs may contribute to the development of inflammatory processes involved in the pathogenesis of T2D. Downregulation of IL1R1 in individuals with mild hyperglycemia may indicate an attempt to reduce the pro-inflammatory effects of IL-1β via auto-stimulation.
AbstractList Innate immune system dysregulation and chronic low-grade inflammation are associated with the pathogenesis of type 2 diabetes (T2D). The aim of this study was to investigate the effect of hyperglycemia on mRNA expression of four inflammatory genes in peripheral blood mononuclear cells (PBMCs) of pre-diabetic and diabetic individuals. In a case-control study, quantitative real-time PCR was used to analyze changes in IL-1β, IL1R1, IL-6, and IL6ST gene expression in PBMCs of 30 T2D patients with high blood glucose levels, 24 diabetic and nondiabetic individuals with moderately high blood glucose levels and 30 controls with normal blood glucose levels. In T2D patients with high blood glucose, IL-1β expression showed a 2.69-fold increase (p = 0.0380), while IL-6 expression levels were 3.45 fold lower (p = 0.0045) versus control subjects. Moreover, compared with control group the expression of IL1R1 and IL-6 genes both were downregulated in individuals with moderately high blood glucose levels by 2.38 (p = 0.0365) and 4.34 fold (p = 0.0027), respectively. In addition, hemoglobin A1C (A1C) levels were positively correlated with IL-1β expression and fasting plasma glucose (FPG) levels showed a positive correlation with IL-1β and a negative correlation with IL-6 expression. The observed changes in both IL-1β and IL-6 mRNA levels in PBMCs may contribute to the development of inflammatory processes involved in the pathogenesis of T2D. Downregulation of IL1R1 in individuals with mild hyperglycemia may indicate an attempt to reduce the pro-inflammatory effects of IL-1β via auto-stimulation.
Objective: Innate immune system dysregulation and chronic low-grade inflammation are associated with the pathogenesis of type 2 diabetes (T2D). The aim of this study was to investigate the effect of hyperglycemia on mRNA expression of four inflammatory genes in peripheral blood mononuclear cells (PBMCs) of pre-diabetic and diabetic individuals. Methods: In a case-control study, quantitative real-time PCR was used to analyze changes in IL-1β, IL1R1, IL-6, and IL6ST gene expression in PBMCs of 30 T2D patients with high blood glucose levels, 24 diabetic and nondiabetic individuals with moderately high blood glucose levels and 30 controls with normal blood glucose levels. Results: In T2D patients with high blood glucose, IL-1β expression showed a 2.69-fold increase (p = 0.0380), while IL-6 expression levels were 3.45 fold lower (p = 0.0045) versus control subjects. Moreover, compared with control group the expression of IL1R1 and IL-6 genes both were downregulated in individuals with moderately high blood glucose levels by 2.38 (p = 0.0365) and 4.34 fold (p = 0.0027), respectively. In addition, hemoglobin A1C (A1C) levels were positively correlated with IL-1β expression and fasting plasma glucose (FPG) levels showed a positive correlation with IL-1β and a negative correlation with IL-6 expression. Conclusion: The observed changes in both IL-1β and IL-6 mRNA levels in PBMCs may contribute to the development of inflammatory processes involved in the pathogenesis of T2D. Downregulation of IL1R1 in individuals with mild hyperglycemia may indicate an attempt to reduce the pro-inflammatory effects of IL-1β via auto-stimulation.
Innate immune system dysregulation and chronic low-grade inflammation are associated with the pathogenesis of type 2 diabetes (T2D). The aim of this study was to investigate the effect of hyperglycemia on mRNA expression of four inflammatory genes in peripheral blood mononuclear cells (PBMCs) of pre-diabetic and diabetic individuals.OBJECTIVEInnate immune system dysregulation and chronic low-grade inflammation are associated with the pathogenesis of type 2 diabetes (T2D). The aim of this study was to investigate the effect of hyperglycemia on mRNA expression of four inflammatory genes in peripheral blood mononuclear cells (PBMCs) of pre-diabetic and diabetic individuals.In a case-control study, quantitative real-time PCR was used to analyze changes in IL-1β, IL1R1, IL-6, and IL6ST gene expression in PBMCs of 30 T2D patients with high blood glucose levels, 24 diabetic and nondiabetic individuals with moderately high blood glucose levels and 30 controls with normal blood glucose levels.METHODSIn a case-control study, quantitative real-time PCR was used to analyze changes in IL-1β, IL1R1, IL-6, and IL6ST gene expression in PBMCs of 30 T2D patients with high blood glucose levels, 24 diabetic and nondiabetic individuals with moderately high blood glucose levels and 30 controls with normal blood glucose levels.In T2D patients with high blood glucose, IL-1β expression showed a 2.69-fold increase (p = 0.0380), while IL-6 expression levels were 3.45 fold lower (p = 0.0045) versus control subjects. Moreover, compared with control group the expression of IL1R1 and IL-6 genes both were downregulated in individuals with moderately high blood glucose levels by 2.38 (p = 0.0365) and 4.34 fold (p = 0.0027), respectively. In addition, hemoglobin A1C (A1C) levels were positively correlated with IL-1β expression and fasting plasma glucose (FPG) levels showed a positive correlation with IL-1β and a negative correlation with IL-6 expression.RESULTSIn T2D patients with high blood glucose, IL-1β expression showed a 2.69-fold increase (p = 0.0380), while IL-6 expression levels were 3.45 fold lower (p = 0.0045) versus control subjects. Moreover, compared with control group the expression of IL1R1 and IL-6 genes both were downregulated in individuals with moderately high blood glucose levels by 2.38 (p = 0.0365) and 4.34 fold (p = 0.0027), respectively. In addition, hemoglobin A1C (A1C) levels were positively correlated with IL-1β expression and fasting plasma glucose (FPG) levels showed a positive correlation with IL-1β and a negative correlation with IL-6 expression.The observed changes in both IL-1β and IL-6 mRNA levels in PBMCs may contribute to the development of inflammatory processes involved in the pathogenesis of T2D. Downregulation of IL1R1 in individuals with mild hyperglycemia may indicate an attempt to reduce the pro-inflammatory effects of IL-1β via auto-stimulation.CONCLUSIONThe observed changes in both IL-1β and IL-6 mRNA levels in PBMCs may contribute to the development of inflammatory processes involved in the pathogenesis of T2D. Downregulation of IL1R1 in individuals with mild hyperglycemia may indicate an attempt to reduce the pro-inflammatory effects of IL-1β via auto-stimulation.
Author Hassan-Zadeh, Vahideh
Akbari, Mohamad
Author_xml – sequence: 1
  givenname: Mohamad
  orcidid: 0000-0003-2468-0648
  surname: Akbari
  fullname: Akbari, Mohamad
  organization: Department of Cell and Molecular Biology, Faculty of Biology, College of Science, University of Tehran
– sequence: 2
  givenname: Vahideh
  surname: Hassan-Zadeh
  fullname: Hassan-Zadeh, Vahideh
  email: hassanzadeh@khayam.ut.ac.ir
  organization: Department of Cell and Molecular Biology, Faculty of Biology, College of Science, University of Tehran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29851525$$D View this record in MEDLINE/PubMed
BookMark eNqFkU9v1DAQxS1URLeFjwDykUsW_4nZRFwoS2krFdFDOUcTZ8waOXawvSo58s1xtFsOHOAyc_m9N6P3zsiJDx4JecnZmrOGvWFNIxiX7brMZs3rhjHJn5AVV1JUteT8hKwWplqgU3KW0ndWEPW2fUZORdsoroRakV_X84Txm5s1jhbohTGoc6J5h_Ty5xQxJRs8DYbeeONgHCGHONMr9Jio9fQOo512GMHRDy6EgX4O5c-9dgiRbtG5tGjvIFv0xfbB5h29LxepoB8t9JgxPSdPDbiEL477nHz9dHm_va5uv1zdbC9uK11zmSsh2MZwaLnhuumVllKLhvXt0ANDgSA3g2qYaltQm9qA7msmB1CyH6TYSBDynLw--E4x_Nhjyt1oky4vgsewT51gdasULxkV9NUR3fcjDt0U7Qhx7h5jK4A6ADqGlCKaPwhn3VJP91hPt9TTHespund_6bTNJZzgcwTr_qt-f1Bbb0Ic4SFEN3QZZheiieC1TZ38t8VvUMyotw
CitedBy_id crossref_primary_10_1016_j_gene_2021_146181
crossref_primary_10_1080_08820139_2020_1793775
crossref_primary_10_3390_biom12070982
crossref_primary_10_1002_iub_2719
crossref_primary_10_1080_08820139_2019_1586917
crossref_primary_10_1016_j_dsx_2022_102591
crossref_primary_10_1080_08820139_2019_1656227
crossref_primary_10_1016_j_dsx_2020_10_012
crossref_primary_10_1007_s11064_024_04257_y
crossref_primary_10_1016_j_sjbs_2020_10_039
crossref_primary_10_3389_fnut_2022_1013055
crossref_primary_10_1080_08820139_2020_1714649
crossref_primary_10_3390_cancers11091402
crossref_primary_10_1007_s00125_020_05179_4
crossref_primary_10_1007_s00403_024_03788_2
crossref_primary_10_1007_s11033_023_08249_z
crossref_primary_10_1039_C9AN01300H
crossref_primary_10_1016_j_diabres_2021_108941
crossref_primary_10_1007_s10787_019_00663_9
Cites_doi 10.1074/jbc.M301977200
10.2337/diabetes.48.4.738
10.1002/(ISSN)1521-4141
10.1084/jem.165.5.1316
10.2337/diabetes.52.3.812
10.1038/nm1185
10.1016/j.diabres.2014.04.006
10.1172/JCI1368
10.1038/nprot.2008.73
10.1007/s10787-018-0458-0
10.1038/nm1166
10.1016/j.cmet.2010.06.011
10.1371/journal.pone.0036949
10.1002/iid3.97
10.1210/jc.2007-0979
10.1152/physrev.90100.2007
10.1152/ajpendo.00718.2006
10.1038/nri2925
10.2337/db06-1650
10.1177/039463201002300105
10.1002/anr.1780320309
10.1038/ni.2865
10.1038/ni.3153
10.1172/JCI200215318
10.1006/bbrc.1996.0389
10.1210/en.2006-0692
10.1016/S0140-6736(05)61032-X
10.1210/jc.2008-0396
10.2337/db05-1404
10.2337/diabetes.52.11.2784
10.1038/sj.ejcn.1601324
10.1016/j.bbrc.2003.10.013
10.1155/2008/892864
10.1055/s-2007-979789
10.1016/S0024-3205(00)00622-6
10.4049/jimmunol.139.6.1911
10.1152/ajpendo.00074.2003
10.2337/diabetes.51.12.3391
10.2337/dc08-1161
10.2337/db14-0731
ContentType Journal Article
Copyright 2018 Taylor & Francis 2018
Copyright_xml – notice: 2018 Taylor & Francis 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1080/08820139.2018.1480031
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1532-4311
EndPage 665
ExternalDocumentID 29851525
10_1080_08820139_2018_1480031
1480031
Genre Article
Journal Article
GrantInformation_xml – fundername: Iran National Science Foundation
  grantid: 94000647
  funderid: 10.13039/501100003968
GroupedDBID ---
00X
03L
0R~
29I
36B
4.4
53G
5GY
5RE
AALUX
AAMIU
AAPUL
AAQRR
ABBKH
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLKL
ABUPF
ABWVI
ABXYU
ACENM
ACGEJ
ACGFS
ACIEZ
ACUHS
ADCVX
ADRBQ
ADXPE
ADYSH
AECIN
AENEX
AEOZL
AFKVX
AFRVT
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
AMPGV
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
DU5
EAP
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
EST
ESX
F5P
H13
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
M4Z
O9-
RNANH
RVRKI
SV3
TBQAZ
TERGH
TFDNU
TFL
TFW
TUROJ
TUS
UEQFS
UHWXJ
V1S
~1N
AAGDL
AAYXX
CITATION
TASJS
.GJ
0BK
34G
39C
5VS
AALIY
AAORF
AAPXX
ABWCV
ABZEW
ACKZS
ADFOM
ADFZZ
AEIIZ
AFLEI
AI.
AJVHN
AWYRJ
BRMBE
CAG
CGR
COF
CUY
CVF
CYYVM
CZDIS
DRXRE
DWTOO
ECM
EIF
JENTW
LJTGL
M44
NPM
NUSFT
QQXMO
VH1
ZGI
ZXP
7X8
ID FETCH-LOGICAL-c413t-2207f1a91f1c8b5c33c280b9dba0e2ea37d580599a574facb403da53bd3273a23
ISSN 0882-0139
1532-4311
IngestDate Fri Sep 05 10:52:36 EDT 2025
Wed Feb 19 02:33:09 EST 2025
Thu Apr 24 23:10:38 EDT 2025
Wed Oct 01 03:14:33 EDT 2025
Tue May 20 10:47:10 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Type 2 diabetes
Hyperglycemia
IL-1β
inflammation
IL-6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c413t-2207f1a91f1c8b5c33c280b9dba0e2ea37d580599a574facb403da53bd3273a23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2468-0648
OpenAccessLink https://figshare.com/articles/journal_contribution/Hyperglycemia_Affects_the_Expression_of_Inflammatory_Genes_in_Peripheral_Blood_Mononuclear_Cells_of_Patients_with_Type_2_Diabetes/7358081
PMID 29851525
PQID 2049551003
PQPubID 23479
PageCount 12
ParticipantIDs informaworld_taylorfrancis_310_1080_08820139_2018_1480031
proquest_miscellaneous_2049551003
crossref_primary_10_1080_08820139_2018_1480031
pubmed_primary_29851525
crossref_citationtrail_10_1080_08820139_2018_1480031
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-10-03
PublicationDateYYYYMMDD 2018-10-03
PublicationDate_xml – month: 10
  year: 2018
  text: 2018-10-03
  day: 03
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Immunological investigations
PublicationTitleAlternate Immunol Invest
PublicationYear 2018
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References CIT0030
CIT0010
CIT0032
CIT0031
van Greevenbroek MM (CIT0037) 2013; 71
CIT0012
CIT0034
CIT0011
CIT0033
Warner SJ (CIT0039) 1987; 139
CIT0014
CIT0036
CIT0013
CIT0035
CIT0016
CIT0038
CIT0015
CIT0018
CIT0017
CIT0019
CIT0041
CIT0040
CIT0021
CIT0020
CIT0001
CIT0023
CIT0022
CIT0003
CIT0025
CIT0002
CIT0024
CIT0005
CIT0027
CIT0004
CIT0026
CIT0007
CIT0029
CIT0006
CIT0028
CIT0009
CIT0008
References_xml – ident: CIT0028
  doi: 10.1074/jbc.M301977200
– ident: CIT0008
  doi: 10.2337/diabetes.48.4.738
– ident: CIT0019
  doi: 10.1002/(ISSN)1521-4141
– ident: CIT0038
  doi: 10.1084/jem.165.5.1316
– ident: CIT0032
  doi: 10.2337/diabetes.52.3.812
– ident: CIT0002
  doi: 10.1038/nm1185
– ident: CIT0011
  doi: 10.1016/j.diabres.2014.04.006
– ident: CIT0041
  doi: 10.1172/JCI1368
– ident: CIT0029
  doi: 10.1038/nprot.2008.73
– ident: CIT0001
  doi: 10.1007/s10787-018-0458-0
– ident: CIT0004
  doi: 10.1038/nm1166
– ident: CIT0040
  doi: 10.1016/j.cmet.2010.06.011
– ident: CIT0020
  doi: 10.1371/journal.pone.0036949
– ident: CIT0031
  doi: 10.1002/iid3.97
– volume: 71
  start-page: 174
  year: 2013
  ident: CIT0037
  publication-title: Neth J Med
– ident: CIT0016
  doi: 10.1210/jc.2007-0979
– ident: CIT0025
  doi: 10.1152/physrev.90100.2007
– ident: CIT0007
  doi: 10.1152/ajpendo.00718.2006
– ident: CIT0009
  doi: 10.1038/nri2925
– ident: CIT0010
  doi: 10.2337/db06-1650
– ident: CIT0024
  doi: 10.1177/039463201002300105
– ident: CIT0006
  doi: 10.1002/anr.1780320309
– ident: CIT0022
  doi: 10.1038/ni.2865
– ident: CIT0014
  doi: 10.1038/ni.3153
– ident: CIT0021
  doi: 10.1172/JCI200215318
– ident: CIT0034
  doi: 10.1006/bbrc.1996.0389
– ident: CIT0015
  doi: 10.1210/en.2006-0692
– ident: CIT0035
  doi: 10.1016/S0140-6736(05)61032-X
– ident: CIT0003
  doi: 10.1210/jc.2008-0396
– ident: CIT0005
  doi: 10.2337/db05-1404
– ident: CIT0017
  doi: 10.2337/diabetes.52.11.2784
– ident: CIT0023
  doi: 10.1038/sj.ejcn.1601324
– ident: CIT0018
  doi: 10.1016/j.bbrc.2003.10.013
– ident: CIT0036
  doi: 10.1155/2008/892864
– ident: CIT0027
  doi: 10.1055/s-2007-979789
– ident: CIT0026
  doi: 10.1016/S0024-3205(00)00622-6
– volume: 139
  start-page: 1911
  year: 1987
  ident: CIT0039
  publication-title: J Immunol
  doi: 10.4049/jimmunol.139.6.1911
– ident: CIT0033
  doi: 10.1152/ajpendo.00074.2003
– ident: CIT0030
  doi: 10.2337/diabetes.51.12.3391
– ident: CIT0012
  doi: 10.2337/dc08-1161
– ident: CIT0013
  doi: 10.2337/db14-0731
SSID ssj0003569
Score 2.279753
Snippet Objective: Innate immune system dysregulation and chronic low-grade inflammation are associated with the pathogenesis of type 2 diabetes (T2D). The aim of this...
Innate immune system dysregulation and chronic low-grade inflammation are associated with the pathogenesis of type 2 diabetes (T2D). The aim of this study was...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 654
SubjectTerms Adult
Aged
Case-Control Studies
Cytokine Receptor gp130 - genetics
Cytokine Receptor gp130 - metabolism
Diabetes Mellitus, Type 2 - immunology
Female
Gene Expression Regulation
Humans
Hyperglycemia
Hyperglycemia - immunology
IL-1β
IL-6
inflammation
Inflammation Mediators - metabolism
Interleukin-1beta - genetics
Interleukin-1beta - metabolism
Interleukin-6 - genetics
Interleukin-6 - metabolism
Leukocytes, Mononuclear - physiology
Male
Middle Aged
Receptors, Interleukin-1 Type I - genetics
Receptors, Interleukin-1 Type I - metabolism
RNA, Messenger - genetics
Type 2 diabetes
Title Hyperglycemia Affects the Expression of Inflammatory Genes in Peripheral Blood Mononuclear Cells of Patients with Type 2 Diabetes
URI https://www.tandfonline.com/doi/abs/10.1080/08820139.2018.1480031
https://www.ncbi.nlm.nih.gov/pubmed/29851525
https://www.proquest.com/docview/2049551003
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1532-4311
  dateEnd: 20241001
  omitProxy: true
  ssIdentifier: ssj0003569
  issn: 0882-0139
  databaseCode: ABDBF
  dateStart: 20010201
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FVCAuCMorvLRI3CpH9vqZY1NaBaSgHlJUcbHG63UbkThVHlLLjX_Bz2Vmd_0IFEq5WJblXW0yn7-d2Z35lrF3bphBLIvIwek5doLcLZwkUB6SoQtC51QqWoccf4pGJ8HH0_C00_nRylrarLO-_HZtXcn_WBWfoV2pSvYWlq07xQd4j_bFK1oYr_9k4xEGkcuz2ZVU8ynQ5oxOzSBX8vDSJriWplakQMPPzYY6CU3rJNhjHKIWFZjtDSl9nb7vRUn6xrDcO1Azo6t8bIRXbRXcxKzY2jyaVdu1_UCVJjWVThv9jmpBkGD1NQNT2j5enMMc8oYAVysonS-QK73O8xnOp3jbXpPwjECsv0VdlPBhZIr6qqJWqs-y1Gq516htWozFLSKNjLS0nZMjc57Eb3Rv8yMTcmN02ZGXIPUnxFTN_Fbt6f8y7dXJiF6lkmq7Samb1HZzh-2IOIpEl-3sD98Pj-pZ3g_1cYn1L62qw0i3_brxbPk9W6q4f45ttI8zecge2OCE7xukPWIdVe6yu-a40qtddm9sEzEes-9b0OMWehyhxxvo8UXB29DjGnp8WvIGelxDj7egxzX0qG0FPU7Q4wQ9LngFvSfs5OhwcjBy7GkejkRHae0I4caFBwOv8GSShdL3pUjcbJBn4CqhwI_zMCG1IAjjoACZBa6fQ-hnuY8uNgj_KeviUNRzxjPiF4oEpAwCqaIEvLjAuAOw46SApMeC6r9OpZW6pxNXZulfbd1j_brZhdF6uanBoG3IdK0X2QpzIk7q39D2bWX1FBmdtumgVIvNCt8KBhjH4Es99szAoR6OGGCEFIrwxW2H-pLdbz7UV6y7Xm7Ua3Sn19kbi-yfb8DB2A
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyperglycemia+Affects+the+Expression+of+Inflammatory+Genes+in+Peripheral+Blood+Mononuclear+Cells+of+Patients+with+Type+2+Diabetes&rft.jtitle=Immunological+investigations&rft.au=Akbari%2C+Mohamad&rft.au=Hassan-Zadeh%2C+Vahideh&rft.date=2018-10-03&rft.issn=0882-0139&rft.eissn=1532-4311&rft.volume=47&rft.issue=7&rft.spage=654&rft.epage=665&rft_id=info:doi/10.1080%2F08820139.2018.1480031&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_08820139_2018_1480031
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0882-0139&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0882-0139&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0882-0139&client=summon